<?xml version="1.0" encoding="UTF-8"?>
<ref id="zoi201035r24">
 <label>24</label>
 <mixed-citation publication-type="confproc">
  <person-group>
   <name name-style="western">
    <surname>Vrancken-Peeters</surname>
    <given-names>MJT</given-names>
   </name>, 
   <name name-style="western">
    <surname>van Loevezijn</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>van der Noordaa</surname>
    <given-names>ME</given-names>
   </name>, 
   <etal/>
  </person-group> Abstract GS5-06: towards omitting breast surgery in patients with a pathologic complete response after neoadjuvant systemic treatment: interim analysis of the MICRA trial (Minimally Invasive Complete Response Assessment). Paper presented at: San Antonio Breast Cancer Symposium; December 13, 
  <year>2019</year>; San Antonio, TX. 
 </mixed-citation>
</ref>
